Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity

European Journal of Endocrinology

Volumn 135, Issue 2, 1996, Pages 205-210

  Maccario, Mauro ^a   Grottoli, Silvia ^a   Razzore, Paola ^a   Procopio, Massimo ^a   Oleandri, Salvatore Endrio ^a   Ciccarelli, Enrica ^a   Camanni, Franco ^a   Ghigo, Ezio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; GROWTH HORMONE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPROLACTINEMIA; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029792355     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350205     Document Type: Article

References (39)

1. Kreisberg RA, Bosheit BR, DiPlacido J, Roddam RF. Insulin secretion in obesity. N Engl J Med 1967;276:314-9
2. Karam JH, Grodsky GM, Forsham PH. Excessive insulin response to glucose in obese subjects measured by immunochemical assay. Diabetes 1963;12:197-201
3. Polosky KS, Given BD, Van Cauter E. 24-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988;82:442-8
4. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanism of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 1980;65: 1273-84
5. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72:51
6. Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M, et al. Arginine potentiates but does not restore the blunted GH response to GHRH in obesity. Metabolism 1992;41:560-3
7. Tornaire J, Pallo D, Pousset G, Bizollon C, Bachelot I. Diminuition de la tolerance glucidique et hyperinsulinism dans l'adénom à prolactine. Nouv Presse Mod 1974;27:1705
8. Landgraf R, Landgraf-Leurs MMC, Weissmann A, Hörl R, von Werder K, Scriba PC. Prolactin: a diabetogenic hormone. Diabetologia 1977;13:99
9. Gustafson AB, Banasiak MF, Kalkhoff RK, Hagen RC, Kim JH. Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effect of late human pregnancy. J Clin Endocrinol Metab 1980;51:242
10. Schernthaner G, Prager R, Punzengruber C, Luger A. Severe hyperprolactinemia is associated with decreaased insulin binding in vitro and insulin resistance in vivo. Diabetologia 1985;28:138
11. Johnston H, Alberti KG, Nattrass M, Burrin JM, Blesa-Malpica G, Hall K, et al. Hyperinsulinemia in hyperprolactinemic women. Clin Endocrinol 1980;13:361
12. Katz EJ, Donald RA, Beaven DW, Espiner EA. Lack of effect of hyperprolactinemie on glucose disposal and insulin secretion in patients with prolactinomas. Horm Metab Res 1981;13:667
13. Brelje TC, Sorenson LR. Role of prolactin versus growth hormone on islet B-cell proliferation in vitro: implications for pregnancy. Endocrinology 1991;128:45
14. Billestrup N, Nielsen JH. The stimulatory effect of growth hormone, prolactin and placental lactogen on B-cell proliferation is not mediated by insulin-like-growth factor I. Endocrinology 1991;129:883
15. Michaels RL, Sorenson RL, Parsons JA, Sheridan JD. Prolactin enhances cell-to-cell communication among B-cells in pancreatic islets. Diabetes 1987;36:1098
16. Camanni F, Ciccarelli E, Ghigo E, Muller EE. Hyperprolactinemia: neuroendocrine and diagnostic aspects. J Endocrinol Invest 1989;12:653
17. Curry DL, Bennett LL, Grodsky CM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968; 83:572
18. Fajans SS, Floyd JC, Knopf RF, Conn JW. Effect of aminoacids and proteins on insulin secretion in man. Recent Progr Horm Res 1967;23:617-62
19. Floyd JC, Fagans JR, Pek S, Tiffualt CA, Knopf RF, Conn JW. Synergistic effect of essential aminoacids and glucose upon insulin secretion in man. Diabetes 1970;19:109-15
20. Levin SR, Karam JH, Hane S, Grodsky GM, Fosham PH. Enhancement of arginine-induced insulin secretion in man by prior administration of glucose. Diabetes 1971;20:171-6
21. Van Haeften TW, Voetberg GA, Gerich JE, Van der Veen EA. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia. J Clin Endocrinol Metab 1989;69:1059
22. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D. Diminished ß-cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1984;74: 1318-28
23. Davies RR, Turner SI, Johnston DG. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone factor 1-44 in normal man. Clin Endocrinol 1984; 21:477-81
24. Penalva A, Burguera B, Casabiell X, Tresguerres JAF, Dieguez C, Casanueva FF. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH)-releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin? Neuroendocrinology 1989;49:551-4
25. Alba-Roth J, Albrecth Muller O, Schopohl J, Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin Endocrinol Metab 1988;67:1186-9
26. Ghigo E, Miola C, Aimaretti G, Valente F, Procopio M, Arvat E, et al. Arginine abolishes the inhibitory effect of glucose on the GH response to GHRH in man. Metabolism 1992;41:1000-3
27. Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting condition and after challenge with glucose. Acta Endocrinol (Copenh) 1975;79:709-12
28. Nielsen JH, Linde S, Wellinder BS, Billestrup N. Madsen OD. Growth hormone is a growth factor for the differentiated B-cell. Mol Endocrinol 1989;13:165
29. Geffner ME, Bersch N, Golde DW. Growth hormone induces Insulin resistance in Laron Dwarf cells via lactogenic receptors. J Clin Endocrinol Metab 1992;76:1039
30. Luger A, Graf H, Prager R, Schernthaner G. Decreased peripheral insulin sensitivity in hyperprolactinemic patients. Acta Endocrinol (Copenh) 1984;105(Suppl 364):44
31. Tannenbaum GS, Lapointe M, Gurd W, Finkelstein JA. Mechanism of impaired growth hormone secretion in genetically obese Zucher rats: roles of growth hormone-releasing factor and somatostatin. Endocrinology 1990;127:3087-95
32. Berelowitz M, Finkelstein JA, Thominet JL, Ting NC, Hirth J, Frohman LA. Impaired growth hormone secretion in spontaneous experimental obesity: a result of increased somatostatin (SRIF) tone. 14th Annu Meet Endoc Soc, San Antonio, TX. 1983. Abstract 84
33. Alvarez CV, Mallo F, Burghera B, Calicedo L, Dieguez C, Casanueva FF. Evidence for direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone releasing hormone in the rat. Neuroendocrinology 1991;53:185-9
34. Penalva A, Gaztambide S, Vasquez JA, et al. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal man. Clin Endocrinol 1990;33:171-6
35. Maccario M, Procopio M, Loche S, Cappa M, Martina V, Camanni F, et al. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 1994;43:223-6
36. Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest 1984;73:1425-33
37. Loche S, Cappa M, Borrelli P, Faedda D, Crinò A, Cella SG, et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf) 1987;27: 145-53
38. Kopelman PG. Neuroendocrine function in obesity. Clin Endocrinol 1988;28:675-89
39. Cavagnini F, Maraschini C, Pinto M, Dubini A, Polli EE. Impaired prolactin secretion in obese patients. J Endocrinol Invest 1981;4:149